Rezultati pretrage - Jonas Saal

  • Prikaz rezultata 1 – 5 od 5
Detaljiziraj rezultate
  1. 1
    Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition

    Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoin... od Jonas Saal, Tobias Bald, Markus Eckstein, Damian J. Ralser, Peter Brossart, Jörg Ellinger, Michael Hölzel, Niklas Klümper

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma

    Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma od Jonas Saal, Tobias Bald, Markus Eckstein, Damian J. Ralser, Manuel Ritter, Peter Brossart, Viktor Grünwald, Michael Hölzel, Jörg Ellinger, Niklas Klümper

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

    C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer od Niklas Klümper, Jonas Saal, Fiamma Berner, Christa Lichtensteiger, Nina Wyss, Annkristin Heine, Franz Bauernfeind, Jörg Ellinger, Peter Brossart, Stefan Diem, Sabine Schmid, Markus Joerger, M. Frueh, Manuel Ritter, Michael Hölzel, Lukas Flatz, Tobias Bald

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma

    C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma od Niklas Klümper, Danijel Sikic, Jonas Saal, Thomas Büttner, Franziska Goldschmidt, Jonas Jarczyk, Philippe C. Becker, Philip Zeuschner, Maximilian Weinke, Charis Kalogirou, Johannes Breyer, Maximilian Burger, Philipp Nuhn, Karl H. Tully, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Ralph M. Wirtz, Michael H. Muders, Glen Kristiansen, Tobias Bald, Jörg Ellinger, Bernd Wullich, Michael Hölzel, Arndt Hartmann, Philipp Erben, Manuel Ritter, Markus Eckstein

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    <i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

    <i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer od Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Günter Niegisch, Camilla M. Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß‐Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Jörg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J. Meeks, Francisco Vera-Badillo, J. Alberto Nakauma-González, Joost L. Boormans, Kerstin Junker, Arndt Hartmann, Viktor Grünwald, Michael Hölzel, Markus Eckstein

    Izdano 2024
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: